Will the Phase 3 trial "Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma" reach primary completion on or before Jun 1, 2027?

Resolves Yes if ClinicalTrials.gov record NCT03895359 (London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's) shows an actual primary completion date on or before Jun 1, 2027. Registered date at generation: Jun 1, 2027.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Jun 1, 2027, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.